Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Foster

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Italian Journal of Gastroenterology and Hepatology|March 17, 1999
Amantadine in the treatment of patients with chronic hepatitis CG R Foster
Alimentary Pharmacology & Therapeutics|October 14, 2004
Review article: pegylated interferons: chemical and clinical differencesG R Foster
Zeitschrift Fur Parasitenkunde (Berlin, Germany)|January 1, 1970
A suggested medium for maintaining Fasciola hepatica prior to in vitro experimentationG R Foster
Journal of the Royal Society of Medicine|September 1, 1988
Behçet's colitis with oesophageal ulceration treated with sulphasalazine and cyclosporinG R Foster
Journal of Viral Hepatitis|August 14, 2009
Quality of life considerations for patients with chronic hepatitis CG R Foster
Journal of Hepatology|January 6, 2000
Hepatitis C virus infection: quality of life and side effects of treatmentG R Foster
Seminars in Liver Disease|January 1, 1997
Interferons in host defenseG R Foster
Lancet (London, England)|April 13, 2005
Apoptotic cell death: the caspase-cleavage "gold rush"G R Foster
Journal of the Medical Association of Georgia|August 1, 1979
The magic word in the effective practice of medicineG R Foster
BMJ (Clinical Research Ed.)|October 6, 2000
Combination treatment for hepatitis C is not being givenG R Foster, R Chapman
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Italian Journal of Gastroenterology and Hepatology|March 17, 1999
Amantadine in the treatment of patients with chronic hepatitis CG R Foster
Alimentary Pharmacology & Therapeutics|October 14, 2004
Review article: pegylated interferons: chemical and clinical differencesG R Foster
Zeitschrift Fur Parasitenkunde (Berlin, Germany)|January 1, 1970
A suggested medium for maintaining Fasciola hepatica prior to in vitro experimentationG R Foster
Journal of the Royal Society of Medicine|September 1, 1988
Behçet's colitis with oesophageal ulceration treated with sulphasalazine and cyclosporinG R Foster
Journal of Viral Hepatitis|August 14, 2009
Quality of life considerations for patients with chronic hepatitis CG R Foster
Journal of Hepatology|January 6, 2000
Hepatitis C virus infection: quality of life and side effects of treatmentG R Foster
Seminars in Liver Disease|January 1, 1997
Interferons in host defenseG R Foster
Lancet (London, England)|April 13, 2005
Apoptotic cell death: the caspase-cleavage "gold rush"G R Foster
Journal of the Medical Association of Georgia|August 1, 1979
The magic word in the effective practice of medicineG R Foster
BMJ (Clinical Research Ed.)|October 6, 2000
Combination treatment for hepatitis C is not being givenG R Foster, R Chapman
Pageof 9